Der er ikke rapporteret klinisk relevant komplementaktivering i kliniske forsøg, men der er under bivirkningsovervågningen efter markedsføring rapporteret om anafylaktiske reaktioner.
No clinically relevant complement activation was reported in clinical trials but anaphylactic reactions have been reported during post-marketing surveillance.